Literature DB >> 8940014

Evidence for a role of glucose-induced translocation of glucokinase in the control of hepatic glycogen synthesis.

L Agius1, M Peak, C B Newgard, A M Gomez-Foix, J J Guinovart.   

Abstract

Glucokinase reversibly partitions between a bound and a free state in the hepatocyte in response to the metabolic status of the cell. Maximum binding occurs at low [glucose] (<5 mM) and minimum binding at high [glucose] or in the presence of sorbitol or fructose. In this study we determined the binding characteristics of glucokinase in the hepatocyte in situ, by adenovirus-mediated glucokinase overexpression combined with the digitonin-permeabilization technique. We also determined the sensitivity of glycogen synthesis to changes in either total glucokinase overexpression or in free glucokinase activity. Glucokinase overexpression is associated with an increase in both free and bound activity, with an overall decrease in the proportion of bound activity. In hepatocytes incubated at low [glucose] (0-5 mM), glucokinase binding involves a high-affinity binding site with a Kd of approximately 0.1 microM and a binding capacity of approximately 3 pmol/mg total cell protein and low-affinity binding with a Kd of approximately 1.6 microM. Increasing glucose concentration to 20 mM causes a dose-dependent increase in the Kd of the high- affinity site to approximately 0.6 microM, and this effect was mimicked by 50 microM sorbitol, a precursor of fructose 1-P, confirming that this site is the regulatory protein of glucokinase. Glycogen synthesis determined from the incorporation of [2-3H,U-14C]glucose into glycogen at 5 mM or 10 mM glucose was very sensitive to small increases in total glucokinase activity and correlated more closely with the increase in free glucokinase activity. The relation between glycogenic flux and glucokinase activity is sigmoidal. Expression of the sensitivity of glycogen synthesis to glucokinase activity as the control coefficient reveals that the coefficient is greater for the incorporation of 2-tritium (which occurs exclusively by the direct pathway) than for incorporation of 14C label (which involves direct and indirect pathways) and is greater at 5 mM glucose (when glucokinase is maximally sequestered at its high-affinity site) than at 10 mM glucose. The results support the hypothesis that compartmentation of glucokinase in the hepatocyte increases the sensitivity of glycogen synthesis to small changes in total glucokinase activity and that glucose-induced translocation of glucokinase has a major role in the acute control of glycogen synthesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8940014     DOI: 10.1074/jbc.271.48.30479

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Occurrence of paradoxical or sustained control by an enzyme when overexpressed: necessary conditions and experimental evidence with regard to hepatic glucokinase.

Authors:  P De Atauri; L Acerenza; B N Kholodenko; N De La Iglesia; J J Guinovart; L Agius; M Cascante
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

2.  Involvement of glucokinase translocation in the mechanism by which resorcinol inhibits glycolysis in hepatocytes.

Authors:  L Agius
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

3.  Protein phosphorylation can regulate metabolite concentrations rather than control flux: the example of glycogen synthase.

Authors:  James R A Schafer; David A Fell; Douglas Rothman; Robert G Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-26       Impact factor: 11.205

4.  The control of hepatic glycogen metabolism in an in vitro model of sepsis.

Authors:  Jennifer Wallington; Jian Ning; Michael Alan Titheradge
Journal:  Mol Cell Biochem       Date:  2007-10-13       Impact factor: 3.396

5.  Kaempferol ameliorates hyperglycemia through suppressing hepatic gluconeogenesis and enhancing hepatic insulin sensitivity in diet-induced obese mice.

Authors:  Hana Alkhalidy; Will Moore; Aihua Wang; Jing Luo; Ryan P McMillan; Yao Wang; Wei Zhen; Matthew W Hulver; Dongmin Liu
Journal:  J Nutr Biochem       Date:  2018-05-01       Impact factor: 6.048

Review 6.  Specific features of glycogen metabolism in the liver.

Authors:  M Bollen; S Keppens; W Stalmans
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

7.  Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat-fed, streptozotocin-treated diabetic rats.

Authors:  Yong Wu; Jing Ping Ouyang; Ke Wu; Shi Shun Wang; Chong Yuan Wen; Zheng Yuan Xia
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

8.  Elevated NEFA levels impair glucose effectiveness by increasing net hepatic glycogenolysis.

Authors:  S Kehlenbrink; S Koppaka; M Martin; R Relwani; M-H Cui; J-H Hwang; Y Li; R Basu; M Hawkins; P Kishore
Journal:  Diabetologia       Date:  2012-07-31       Impact factor: 10.122

9.  Preclinical PK/PD modeling and human efficacious dose projection for a glucokinase activator in the treatment of diabetes.

Authors:  Michael G Zager; Kirk Kozminski; Bernadette Pascual; Kathleen M Ogilvie; Shaoxian Sun
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-02-28       Impact factor: 2.745

Review 10.  Molecular physiology of mammalian glucokinase.

Authors:  P B Iynedjian
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.